Literature DB >> 19423265

Circulating CA125 and diffuse malignant peritoneal mesothelioma.

D Baratti, S Kusamura, M Deraco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423265     DOI: 10.1016/j.ejso.2009.04.007

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


× No keyword cloud information.
  3 in total

1.  A novel nomogram for peritoneal mesothelioma predicts survival.

Authors:  Nicholas P Schaub; Meghna Alimchandani; Martha Quezado; Phil Kalina; John S Eberhardt; Marybeth S Hughes; Tatiana Beresnev; Raffit Hassan; David L Bartlett; Steven K Libutti; James F Pingpank; Richard E Royal; Udai S Kammula; Prakash Pandalai; Giao Q Phan; Alexander Stojadinovic; Udo Rudloff; H Richard Alexander; Itzhak Avital
Journal:  Ann Surg Oncol       Date:  2012-12-12       Impact factor: 5.344

Review 2.  Advances in the management of peritoneal mesothelioma.

Authors:  Ali Raza; Wei-Ching Huang; Kazuaki Takabe
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Clinical significance of serum CA125 in diffuse malignant mesothelioma.

Authors:  Xu Cheng; Hong-Feng Gou; Ji-Yan Liu; De-Yun Luo; Meng Qiu
Journal:  Springerplus       Date:  2016-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.